AnaBios

AnaBios offers high-quality human tissue and cells recovered through an extensive network of hospitals and organ procurement organizations. The company utilizes proprietary methods, practices, and streamlined logistics to maximize the preservation of physiological function. AnaBios provides human tissue and cells for scientific research and drug discovery, having developed proprietary processes for functional ex vivo human platforms that redefine the concept of ‘First in Human’ studies. The company acquired Cell Systems, a human primary cell and cell culture media company located in Kirkland, Washington, and offers a variety of human primary cells, including endothelial cells from the brain, liver, kidney, eye, and lung. AnaBios provides functional assays such as CardioPRIME, Heart Tissue Assays, Pain-Related Assays, and Neurotoxicity Assays, focusing research on areas of high, unmet medical need, including cardiac disease and safety, pain, and neurodegeneration. The company provides high-quality human tissue samples with high RNA Integrity Numbers (RIN scores) and offers human tissue-based models for a variety of therapeutic areas, including pain, itch, atrial fibrillation, heart failure, fibrosis, and kidney disease. AnaBios supplies human primary cells and tissues for the pharmaceutical industry and academic laboratories globally. The company developed a human cardiomyocyte-based model that has the potential to provide a predictive preclinical approach for simultaneously predicting drug-induced inotropic and pro-arrhythmia risk. AnaBios offers human DRG tissue samples for pain and sensory processing research and provides cryopreserved human precision-cut lung slices (PCLS) as an ex vivo preparation that maintains the complex cellular composition, native architecture, and functionality of human lung tissue. Additionally, the company offers high-quality human hepatocytes for drug metabolism and toxicity studies.